Patents Examined by Manuel Mendez
  • Patent number: 11452819
    Abstract: A medication delivery device with a sensing system to determine at least one of a dose set and a dose delivery. The sensing system is operable to detect relative rotational positions of first and second members of the device which are indicative of at least one of an amount of a dose set and an amount of a dose delivered by operation of the device, and generate outputs correlated to such relative rotational positions. The system includes a wiper coupled to the first member, and a sensing band coupled to the second member for physically contacting the wiper as the second member rotates relative to the first member. A controller electrically communicates with the sensing system to determine, based on the generated outputs of the sensing system, at least one of the amount of the dose set and the amount of the dose delivered by operation of the device.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: September 27, 2022
    Assignee: Eli Lilly and Company
    Inventors: Uri Eliezer Baruch, James Angus Boonzaier, Xorge Castro Pelayo, Matthew James Clemente, Jeremy Peter Clements, James Alexander Davies, Robert Eugene Trzybinski
  • Patent number: 11446439
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: September 20, 2022
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 11439754
    Abstract: Disclosed herein is a method for execution by a drug delivery device for determining an optimal dose of a liquid drug for current cycle of a medication delivery algorithm, the method utilizing a stepwise evaluation of a model and a cost function across a coarse search space consisting of coarse discrete quantities of the drug and a refined search space consisting of refined discrete quantities of the drug.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: September 13, 2022
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Yibin Zheng, Jason O'Connor, Ashutosh Zade
  • Patent number: 11439218
    Abstract: A system and method for dermal spraying includes a portable, hand-held dermal application device with disposable formulation capsules that spray a formulation unto the skin and a data transmission unit operatively connecting the dermal spray device to a mobile device. The mobile device communicates with a remote server and transmits anonymized data about the user's skin conditions and treatment history. The anonymized data may be labelled and classified by a dermatologist, and stored on a secure cloud server. The anonymized data is used to train models for serum and treatment plan recommenders.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: September 13, 2022
    Assignee: KOZHYA LLC SP. Z O.O.
    Inventors: Yoanna A. Gouchtchina, Enrique Gallar
  • Patent number: 11433182
    Abstract: A drug delivery device comprises first and second liquid drug reservoirs and first and second outlet ports. A drive is configured for expelling a first liquid drug from the first reservoir to the first outlet port and for expelling a second liquid drug from the second reservoir to the second outlet port. A memory is provided that contains a drug dosing scheme specifying a desired liquid drug type, and at least one sensor is provided that detects information concerning the type of liquid drug contained in the first and/or second reservoir. A processor receives the information from the at least one sensor and thereby determines the type of liquid drug retained in the first reservoir and/or the second reservoir, and uses the drug dosing scheme and the determined type of liquid drug to operate the drive. Associated devices this disclosure and methods are also disclosed.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: September 6, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Frank Deck, Hans List
  • Patent number: 11433184
    Abstract: An automated system of regulation of a patient's blood glucose, including: a blood glucose sensor; an insulin injection device; and a processing and control unit capable of predicting, from a physiological model, the future evolution of the patient's blood glucose over a prediction period, and of controlling the insulin injection device by taking the prediction into account, wherein the processing and control unit is capable of: a) calibrating the physiological model, taking into account the blood glucose measured by the sensor during a past observation period; b) at the end of the calibration, calculating an indicator representative of the error between the blood glucose estimated from the model and the real blood glucose measured by the sensor; and c) adjusting the prediction period by taking into account the value of the indicator.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: September 6, 2022
    Assignee: Commissariat à l'Énergie Atomique et aux Énergies Alternatives
    Inventors: Eléonore Doron, Sylvain Lachal, Pierre Jallon
  • Patent number: 11430557
    Abstract: An aspect of the invention provides a method and a product for determining a modification of the therapy management by using a processor unit which retrieves few data related to the blood glucose measurement performed over a predetermined time period; retrieve the medication delivery parameter executed by the delivery device over said predetermined time period; retrieve from the memory data associated to the CIR of the patient; and determine a modification to the therapy based on at least a part of the retrieved data.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: August 30, 2022
    Assignees: UNIVERSITÄT BERN, DEBIOTECH S.A.
    Inventors: Stavroula Mougiakakou, Qingnan Sun, Marko Jankovic, Laurent-Dominique Piveteau, Stephan Proennecke, João Budzinski
  • Patent number: 11413395
    Abstract: Systems and methods are described for presenting information for managing a vital sign of a patient. A graphical user interface (GUI) can be presented that displays information concerning a vital sign of a patient, including the most current value of the vital sign received and past values of the vital sign over an elapsed time period. Using this information, a time in target value can be generated representing an amount of elapsed time the patient's measured vital sign was within a predetermined range. Preferably, the systems and methods are used with a closed-loop system that may automatically adjust a dosage rate of a medication, although manual control is also contemplated. The GUI may comprise one or more visual indicators presented on the historical data that, when selected, present additional information that may be useful to managing the care of the patient.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: August 16, 2022
    Assignee: Perceptive Medical Inc.
    Inventors: Joseph Rinehart, Douglas Patton, Morgan McKeown
  • Patent number: 11413404
    Abstract: Heat treatment apparatus for inactivating viruses in blood includes a series of four tubing coils with connectors at the opposite ends of the series for connecting the tubing to a blood source and a blood destination, a microwave heating chamber arranged to receive the first coil of the series, a dwell chamber to receive the second coil of the series, a cooling chamber adapted to receive the third coil of the series, and a microwave reheating chamber to receive the fourth coil of the series, with the first, second, and fourth chambers employing microwave energy for heating the blood as it flows within the coils and providing a radiometer circuit for monitoring the temperatures of the blood in the first, second, and fourth coils to produce first, second, and fourth temperature signals in response thereto, which is responded to by a controller to control the energy producing means to impart a selected time/temperature profile to the blood flowing through the tubing and to deliver that blood at a selected delive
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: August 16, 2022
    Inventor: Kenneth L. Carr, Jr.
  • Patent number: 11413420
    Abstract: A gas delivery device includes a nitric oxide generating system. The system has a medium including i) a source of nitrite ions, or ii) a source of nitrite ions and a Cu(II)-ligand complex. A working electrode is in contact with the medium, wherein i) when the medium includes the source of nitrite ions, the working electrode is a copper containing conductive material or a base material coated with a copper containing conductive material, or ii) when the medium includes the source of nitrite ions and the Cu(II)-ligand complex, the working electrode is platinum, gold, carbon, a carbon coated material, and/or mercury. A reference/counter electrode is in contact with the medium and electrically isolated from the working electrode. An inlet conduit is to deliver oxygen gas to the medium, and an outlet conduit is to transport a stream of oxygen gas and nitric oxide from the medium.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: August 16, 2022
    Assignee: The Regents of the University of Michigan
    Inventors: Mark E. Meyerhoff, Lajos Hofler, Dipankar Koley, Hang Ren
  • Patent number: 11406756
    Abstract: An at least partly implantable system for injecting a substance into a patient's body. The system comprises at least one flexibly bendable infusion needle with a tip end of each of said at least one infusion needle arranged in at least one first housing for penetrating the first housing's outer wall in at least one penetration area and having the respective other end arranged in at least one second housing, the first and second housings being adapted for implantation inside the patient's body, wherein the at least one second housing is provided for implantation inside the patient's body remote from the at least one first housing and wherein the injection needle is sufficiently long to bridge the distance from the at least one second housing for remote implantation to the at least one first housing and further through the first housing up to the outer wall of the first housing.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: August 9, 2022
    Inventor: Peter Forsell
  • Patent number: 11406767
    Abstract: A feedback mechanism for an injection device that is configured to deliver a medicament to a user is described. The feedback mechanism has a biasing member that is arranged to apply a force to a delay element, and the delay element is configured to deform and/or break under the force. The feedback mechanism also includes an indicator arranged to generate user feedback after the delay element is deformed and/or broken. The delay element is configured to deform and/or break at a time after the force is applied by the biasing member to create a delay before the user feedback is generated.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: August 9, 2022
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Martin Baumeyer, Peter Nober, Matthias Rau, Winfried Huthmacher, Markus Janiak
  • Patent number: 11406801
    Abstract: An exoskeleton device is capable of being positioned over an expandable instrument, such as a balloon catheter. The exoskeleton device may include an expandable section that receives an expander of the expandable instrument. Expansion of the expander may cause the expandable section of the exoskeleton device to expand and force the expandable section of the exoskeleton device against a surface to be treated. The expandable section may be capable of scoring the surface against which it is forced.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: August 9, 2022
    Assignee: Transit Scientific, LLC
    Inventors: Shawn P. Fojtik, Greg Method, Jennifer Arnold
  • Patent number: 11400209
    Abstract: An infusion device. The infusion device includes a top portion comprising an introduction needle, and a bottom portion comprising a cannula, the top portion removably attached to the bottom portion, wherein the introduction needle is used to insert the cannula, and wherein after insertion, the top portion is removed from the bottom portion.
    Type: Grant
    Filed: September 16, 2019
    Date of Patent: August 2, 2022
    Assignee: DEKA PRODUCTS LIMITED PARTNERSHIP
    Inventors: Dean Kamen, Kevin L. Grant
  • Patent number: 11400237
    Abstract: Provided is a medicine infusion apparatus capable of infusing a liquid medicine into a human body by using a medicine container configured to discharge the liquid medicine contained therein, along a designated path when a pressure is applied from outside, the medicine infusion apparatus including one or more medicine pressing units including one or more inflatable parts capable of being inflated by air to apply a pressure to the medicine container, a first pumping unit capable of inflating one of the inflatable parts by including a first pump capable of generating air of a preset pressure, and a first pipe connectable to the one of the inflatable parts, and a heating unit including a thermoelectric module capable of heating the medicine within a preset temperature range. According to the present invention, the medicine infusion apparatus may be produced as a compact portable apparatus by using a low-capacity battery and be used for emergencies at accident sites where electricity may not be easily supplied.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: August 2, 2022
    Assignee: IMPACT KOREA CO., LTD.
    Inventor: Moung Sook Lee
  • Patent number: 11383035
    Abstract: Disclosed herein is a method for execution by a drug delivery device for determining an optimal dose of a liquid drug for current cycle of a medication delivery algorithm, the method utilizing a stepwise evaluation of a model and a cost function across a coarse search space consisting of coarse discrete quantities of the drug and a refined search space consisting of refined discrete quantities of the drug.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: July 12, 2022
    Assignee: INSULET CORPORATION
    Inventors: Joon Bok Lee, Yibin Zheng, Jason O'Connor, Ashutosh Zade
  • Patent number: 11383024
    Abstract: A system for providing multiple infusions to a patient (P), the system comprises a multiplicity of infusion devices (10) for administering a multiplicity of medical fluids through an infusion line (102) of an infusion set (103) to the patient (P), and a control device (2) for controlling the multiplicity of infusion devices (10). Herein, the control device (2) comprises a multiplex module (22) configured to multiplex the multiplicity of medical fluids for a multiplexed administration of the medical fluids through said infusion line (102) of the infusion set (103), the multiplex module (22) comprising a scheduling module (222) configured to define at least two packets, each packet comprising at least one medical fluid out of the multiplicity of medical fluids, and to arrange the at least two packets in a sequence for administration of the medical fluids of the at least two packets.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: July 12, 2022
    Assignee: Fresenius Vial SAS
    Inventors: Pauline Cottin, Alexandre Guerrini, Frank Doesburg, Maarten Nijsten
  • Patent number: 11383020
    Abstract: Variables of a surgical system are detected or received via one or more sensors to predict an intraocular pressure (IOP) and/or determine an IOP in real time during a surgical procedure. A notification to a surgeon or a target IOP is set and maintained as determined by Static IOP, dynamic IOP, and/or a total IOP combining both static and dynamic IOP of the anterior chamber of a patient's eye. Information collected about various components of the system are displayed on a user interface. The system uses the collected information to calculate the static IOP and/or dynamic IOP of the system, and the total IOP may be function of the static IOP and/or dynamic IOP measurements.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: July 12, 2022
    Assignee: Johnson & Johnson Surgical Vision, Inc.
    Inventors: Sandra H. Keh, Dung T. Ma, Deep Mehta
  • Patent number: 11376058
    Abstract: A plasma instrument includes an elongated body defining a lumen therethrough, the lumen being in fluid communication with an ionizable media source; and a plasma applicator coupled to a distal portion of the elongated body. The plasma applicator includes: an active electrode configured to couple to an active terminal of a generator; and a corona electrode configured to couple to a return terminal of a generator. The plasma instrument also includes a switching element coupled to the corona electrode, the switching element configured to control at least one of resistivity or connectivity of the corona electrode to a generator.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: July 5, 2022
    Assignee: Covidien LP
    Inventors: Arlen K. Ward, Duane E. Kerr
  • Patent number: 11376363
    Abstract: A medicament delivery device includes a generally elongated tubular housing having opposite proximal and distal parts; a needle shield sleeve slidably and coaxially arranged inside the housing with a proximal part of the sleeve protruding a distance outside the proximal part of the housing; a syringe carrier mechanism having a syringe carrier slidably and coaxially arranged within the needle shield sleeve, a syringe having a stopper, a medicament, and a needle, the syringe being coaxially arranged within the syringe carrier; and a holding member connected to the syringe carrier; a first activator member an a second activator member; a drive mechanism adapted to accumulate a drive force for moving the syringe carrier mechanism in a first step and a second step. The second activator member is arranged within an information device for producing audible, visual, and/or tactile feedback to a user about a completed injection.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: July 5, 2022
    Assignee: SHL MEDICAL AG
    Inventor: Oscar Alexandersson